跳至主要内容
临床试验/NL-OMON48191
NL-OMON48191已完成不适用

An exploratory, non-interventional study to biotype patients with facioscapulohumeral muscular dystrophy (FSHD) and controls using digital technologies - Digital biotyping of FSHD patients and controls.

Facio Therapies0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
12 至 99(—)

入选标准

  • * FSHD patients:
  • Genetically confirmed FSHD.
  • Symptomatic, as demonstrated by Lamperti score >0.
  • Android-based smartphone with Android version 5.0 or higher.
  • Age 16+ years.;* Controls:
  • Unrelated subjects without FSHD.
  • Android-based smartphone with Android version 5.0 or higher.
  • Age 16+ years.

排除标准

  • * FSHD patients:
  • Inability to give consent.
  • Current or previously diagnosed illness or any clinical condition that, in the opinion of the investigator, might confound the results of the study.;* Controls:
  • Inability to give consent.
  • Current or previously diagnosed illness or any clinical condition that, in the opinion of the investigator, might confound the results of the study.

研究者

发起方
Facio Therapies

相似试验